Blog - Page 2025 of 5641

MondayFeb 04, 2019 9:28 am

QualityStocksNewsBreaks – Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) Completes Additional Investment in Canapar Corp., Expands Ownership Stake to 49 Percent

Cannabis-focused investment and operating firm Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) this morning announced its completion of a subsequent $9.4 million equity investment in portfolio company Canapar Corp. (“Canapar Canada”), the Canadian parent corporation of Italian organic hemp production and processing platform Canapar SrL (“Canapar Italy”). Per the update, this investment aligns with Canopy’s globally-focused growth strategy and is expected to provide the company with an opportunity to capitalize on the rapidly expanding European cannabidiol market. With its most recent investment, Canopy’s ownership position in Canapar Canada has expanded to 49 percent on a non-diluted basis. “Canopy Rivers’ investment…

FridayFeb 01, 2019 3:20 pm

QualityStocksNewsBreaks – Icon Exploration Inc. (TSX.V: IEX.H) Aims to Capitalize on the Medical and Recreational Cannabis Markets

Icon Exploration (TSX.V: IEX.H), a company working toward establishing its foothold in the global cannabis sector, is planning on operating within both the medical and recreational cannabis markets. An article discussing the company reads, “In what is a win-win situation for Icon, the company has placed bets on both recreational and medical cannabis. This legal market is growing at double-digit rates, and capitalizing on that growth, Icon is aiming to create a well-diversified company that produces long-term returns for shareholders. To do so, it intends to be a leading purveyor of medicinal and recreational cannabis while, at the same time,…

FridayFeb 01, 2019 3:16 pm

QualityStocksNewsBreaks – BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT) Advances Development of Personalized Immunotherapy Solution for Cancer Patients

BriaCell Therapeutics (OTCQB: BCTXF) (TSX.V: BCT), a biotechnology company focused on immuno-oncology, is advancing the development of a cost-saving solution for cancer patients. An article discussing the company reads, “BriaCell’s development of Bria-OTS, a personalized immunotherapy solution that matches the needs of the patient without a specialized manufacturing process, is designed to mitigate some of those worries. This personalized treatment is expected to be safe and highly effective while avoiding the high costs of creating personalized treatments for advanced cancer patients. In addition, Bria-OTS is created to produce a selective immune response that’s tailored to the specific needs of the…

FridayFeb 01, 2019 10:52 am

QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ) Preparing Test Production of Saleable Lithium Material

QMC Quantum Minerals is exploring for lithium at the Irgon Mine site in southern Manitoba, which is located nearby the world-class TANCO Deposit, another very productive, lithium-bearing granitic pegmatite The company is entering into talks with testing firm SGS Canada to begin the process of testing production of a saleable lithium product SGS’s evaluation of QMC’s site recently discovered two unexpected geochemical soil anomalies believed to indicate additional, adjacent, lithium-bearing pegmatite dikes Recent successes in exploring for spodumene-bearing pegmatite dikes on its 100 percent-owned Irgon Property are leading QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ) to begin…

FridayFeb 01, 2019 10:34 am

BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT) Advances Personalized Immunotherapy Technology Targeting Advanced Breast Cancer Patients

Completed development of novel, frozen formulation of Bria-IMT for on-demand shipment to clinical sites New formulation to accommodate higher patient volumes at reduced per-dose costs Mechanism of action and proof of concept achieved in FDA-approved clinical trial with advanced breast cancer patients The global cancer immunotherapy market is expected to be valued at nearly $125 billion by the end of 2024 Breast cancer remains one of the most commonly diagnosed cancers among women globally, with 2.1 million cases expected in 2018 Battling a cancer prognosis is often referred to as “fighting the good fight,” but it’s a tough, uphill battle…

FridayFeb 01, 2019 10:13 am

Net Element Inc. (NASDAQ: NETE) Leading the Way in Transaction-Based Technological Innovation

Leader in technological innovation and world-class customer service Launched Netevia in-app payments software development kit Focused on the creation of a unified global transaction acceptance ecosystem In a fiercely competitive environment, Net Element Inc. (NASDAQ: NETE) stands out for its technological innovation and world-class customer service. Specializing in mobile payments and value-added transactional services, the company has set itself apart as one of the fastest-growing companies in North America, according to Deloitte’s 2017 Technology Fast 500 and the South Florida Business Journal. This one-stop, omni-channel processing solution provides over 100 payment solutions. In North America, NETE’s transactions revenues rose over…

FridayFeb 01, 2019 10:08 am

QualityStocksNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Releases Construction Update, Increases Capacity, Confirms On-Schedule Launch of Growers Circle

Cannabis-focused research and development company The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF) today released a detailed construction update on its domestic Valleyfield and Hamilton operations that reflects significant progress toward the completion of both facilities. According to the update, as a result of a recently-identified need for design modifications in the construction process, the engineering improvements enable optimized facility throughput that, combined with organic specific modifications, provide an increased domestic productive capacity forecast from 156,000 kg to 202,500 kgs. The updated construction plan requires increased capital expenditures of approximately $30 million for the completion of the structures and…

FridayFeb 01, 2019 10:01 am

QualityStocksNewsBreaks – SinglePoint, Inc. (SING) CEO Reiterates Bullish Position on CBD in Episode of MoneyTV with Donald Baillargeon

Technology and investment company SinglePoint (OTCQB: SING) was featured on this week’s episode of MoneyTV with Donald Baillargeon. The internationally-syndicated program covers money-focused topics, featuring in-depth CEO and executive interviews from various companies offering insights into their operations and future outlooks. SinglePoint CEO Greg Lambrecht appeared on this week’s program and reiterated the company’s bullish position on CBD. “Since the house, the senate and President Trump signed the bill making CBD legal it’s just been an explosion. We've been fortunate to be in a great position. We've had our SingleSeed.com site up for almost two years,” SinglePoint CEO Greg Lambrecht…

FridayFeb 01, 2019 9:26 am

QualityStocksNewsBreaks – The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTCQX: SPRWF) (FRA: 53S1) to Commence Trading on the Toronto Stock Exchange

The Supreme Cannabis Company (TSX.V: FIRE) (OTCQX: SPRWF) (FRA: 53S1), a Canadian company dedicated to providing premium brands and products that proudly reflect its consumers, people and uniquely innovative culture, recently announced that its listed securities are anticipated to begin trading on the Toronto Stock Exchange ("TSX") on February 4, 2019. SPRWF is also set to participate in the market open ceremony that day. The company’s common shares and 6.0% senior unsecured convertible debentures due 2021 will be voluntarily delisted from the TSX Venture Exchange under the symbol "FIRE" and will start trading on the TSX under the symbol "FIRE.DB".…

ThursdayJan 31, 2019 3:08 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Seeks to Improve Lives through Revolutionary Nicotine Delivery Method

Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) recently announced that its wholly owned subsidiary, Lexaria Nicotine LLC, has joined forces with one of the world’s largest tobacco companies to fund the research and development of Lexaria’s patented DehydraTECHÔ technology to potentially commercialize a form of oral nicotine delivery. An article discussing the company reads, “Lexaria’s goal is to create an oral product that eliminates the need for inhalation and helps curb the smoking habits of consumers. Over 6 million deaths a year worldwide are attributed to nicotine delivery through smoking. The company believes that its DehydraTECH technology may help the 69…

Site Search

Company Search